REG - Alkemy Capital Invs. - Publication of a Prospectus

Alkemy Capital InvestmentsAnnouncement

25/02/2022 14:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220225:nRSY9078Ca&default-theme=true

RNS Number : 9078C  Alkemy Capital Investments PLC  25 February 2022

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS AN ADVERTISEMENT AND
IS NOT A PROSPECTUS AND NOT AN OFFER FOR SECURITIES FOR SALE IN ANY
JURISDICTION, INCLUDING IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN
OR THE REPUBLIC OF SOUTH AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO
MIGHT CONSTITUTE A VIOLATION OR BREACH OF ANY APPLICABLE LAW. INVESTORS SHOULD
NOT PURCHASE OR SUBSCRIBE FOR ANY SHARES REFERRED TO IN THIS ANNOUNCEMENT
EXCEPT ON THE BASIS OF INFORMATION IN THE PROSPECTUS (THE "PROSPECTUS")
PUBLISHED BY ALKEMY CAPITAL INVESTMENT PLC, IN CONNECTION WITH THE PROPOSED
ADMISSION OF ITS ORDINARY SHARES TO THE STANDARD LISTING SEGMENT OF THE
OFFICIAL LIST OF THE FINANCIAL CONDUCT AUTHORITY AND TO TRADING ON THE MAIN
MARKET FOR LISTED SECURITIES OF LONDON STOCK EXCHANGE PLC (THE "LONDON STOCK
EXCHANGE" OR "LSE") (TOGETHER, "ADMISSION"). THE PROSPECTUS IS AVAILABLE ON
THE COMPANY'S WEBSITE AT WWW.ALKEMY (http://www.alkemy) CAPITAL.CO.UK.

 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED IN IT IS NOT FOR RELEASE,

PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR THE REPUBLIC OF SOUTH
AFRICA OR INTO ANY OTHER JURISDICTION WHERE TO DO SO MIGHT CONSTITUTE A
VIOLATION OR BREACH OF ANY APPLICABLE LAW.

 

25 February 2022

 

Alkemy Capital Investments Plc

("Alkemy" or the "Company)

 

Publication of Prospectus

 

Alkemy is pleased to announce that its prospectus (the "Prospectus") in
support of its intention to re-list on the London Stock Exchange has been
approved by the Financial Conduct Authority and was published today.

 

The Prospectus is being issued in connection with the Company's application
for admission of its entire issued share capital, being 5,999,999 ordinary
shares or £0.02 each ("Ordinary Shares") to the Standard segment of the
Official List and to trading on the London Stock Exchange's Main Market for
listed securities ("Re-admission").

 

The Company expects that Re-admission will become effective and that dealings
in the Ordinary Shares will commence on 2 March 2022 at 8.00 a.m. (London
time) under the ticker symbol: ALK.

 

A copy of the Prospectus will be submitted to the National Storage Mechanism
and will shortly be available for inspection (subject to securities laws) at
www.data.fca.org.uk/#/nsm/nationalstoragemechanism
(http://www.data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

The Prospectus is available on the Company's website at
www.alkemycapital.co.uk (http://www.alkemycapital.co.uk) .

 

 

** Ends **

 

For further information, please contact:

 

Sam Quinn

Director, Alkemy Capital Investments Plc

Telephone: 0207 317 0636

Email: info@alkemycapital.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PDIZZGZZDKFGZZM